carbapenems has been researched along with apramycin in 5 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (apramycin) | Trials (apramycin) | Recent Studies (post-2010) (apramycin) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 167 | 6 | 68 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Aboklaish, AF; Böttger, EC; Cao, S; Crich, D; Ercan, O; Hobbie, SN; Hughes, D; Huseby, DL; Juhas, M; Petersson, A; Polikanov, YS; Rominski, A; Teo, J; Tyrrell, JM; Walsh, TR; Widlake, E | 1 |
Becker, K; Gysin, M; Haldimann, K; Hobbie, SN; Plattner, M | 1 |
Friberg, LE | 1 |
Chen, L; Du, H; Fouts, DE; Hao, M; Kreiswirth, BN; Satlin, M; Schuyler, J; Shashkina, E; Zhang, H | 1 |
Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
5 other study(ies) available for carbapenems and apramycin
Article | Year |
---|---|
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa; Aminoglycosides; Anti-Bacterial Agents; Asia; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Nebramycin; South America; Whole Genome Sequencing | 2019 |
Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Catalytic Domain; Databases, Genetic; Drug Resistance, Bacterial; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Molecular Epidemiology; Mutagenesis, Site-Directed; Nebramycin; Standard of Care; Structure-Activity Relationship | 2020 |
Pivotal Role of Translation in Anti-Infective Development.
Topics: Aminoglycosides; Anti-Infective Agents; Antiviral Agents; Carbapenems; Dose-Response Relationship, Drug; Drug Approval; Drug Development; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Models, Biological; Nebramycin; Research Design; United States; United States Food and Drug Administration | 2021 |
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
Topics: Anti-Bacterial Agents; Carbapenems; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nebramycin | 2021 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |